MCTC Holdings Inc. (MCTC) Announces Drive to Make THC-V Extract Useful at Nanoparticle Levels

January 21, 2020 12:25:41
  • MCTC Holdings Inc. (soon to become Cannabis Global Inc.) is a cannabis science innovator working to develop marketable infusion technologies based on the premise of cannabinoid extract efficiency at extremely low quantities
  • MCTC recently announced the launch of Project Varin, an effort to develop nanoparticle and nano fiber expressions of ultra-rare tetrahydrocannabivarin (THC-V) and to make those useful biologically at such extremely small levels
  • The company also plans to develop the rare cannabinol (CBN) extract by the same means
  • MCTC recently announced a new revenue stream through an infused coffee product under its Hemp You Can Feel label

Visionary cannabinoid science innovator MCTC Holdings Inc. (OTC: MCTC) is announcing a strategic effort to develop an efficient nanoparticle-based means of using the rare but potentially serviceable tetrahydrocannabivarin (THC-V) extract for purposes such as appetite suppression and obesity reduction.

Since reorganizing its management last year to focus its budding cannabis industry strategy on the science of alcohol replacement, MCTC Holdings has indicated its intentions to patent delivery methods that use minuscule particles of cannabis for a low-quantity but high-efficiency series of products. To that end, the company’s research and development strategy has included plans to delve into the potential of cannabis-based polymeric solid nanoparticles and nanofibers.

The company’s recent announcement states that it has launched Project Varin with the primary goal of developing THC-V delivery methods that significantly improve its bioavailability, using MCTC’s patent-pending technologies to produce THC-V polymeric nanoparticles and nanofibers (

“THC-V is so rare and difficult to obtain, it is currently valued at around $500,000 per kilogram, which is approximately ten times the price of gold,” CEO Arman Tabatabaei stated in the news release. “In order for the marketplace to utilize this potentially beneficial exotic cannabinoid, new delivery systems will need to be developed to allow the amount of THC-V administered to be efficiently utilized by the human body… It is our goal to solve this pressing industry issue. Based on our already completed laboratory accomplishments and our patent-pending technologies, we believe this goal is within our reach.”

Nanoparticles have long been used by the food and medical industries to make products more efficient, turning extremely small substances into a means of quickly delivering their payloads directly to the bloodstream rather than following the dilutive and dilatory digestive tract mechanism commonly employed for swallowed products.

MCTC has been working toward an infused beverage product as a replacement for alcohol, and recently announced that it has developed a cannabinoid-infused clean label coffee that will be rolled out later this month under the company’s Hemp You Can Feel™ brand ( MCTC plans to use its efficiency-promoting patents to harvest the benefits of cannabinoid extracts from very small amounts of the extract while achieving results that are similar or superior to other infusion methods, and to license its technology to other companies on a white label basis.

Under the first stage of development for THC-V, Project Varin is developing nanoparticle and nanofiber expressions of the extract using MCTC’s technology. In March, the second phase of development is expected to begin as the company applies its ongoing cannabinoid glycosides research to making THC-V useful at minimal usage levels.

“Interest in THC-V and Cannabinol (CBN) is quickly growing within the cannabinoid industry, and we believe both will be important topics throughout 2020 and beyond,” Tabatabaei stated. “With the recent availability of nearly 100% pure research quantities of these exotic cannabinoids now hitting the marketplace and the piquing interest, we believe our timing in launching Project Varin is optimal. … We plan to apply what we have learned and our new patent-pending technologies to THC-V and eventually to CBN.”

MCTC has filed five patents on hemp extract technologies and delivery systems.

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.